A board-certified wellness coach shares 5 bed exercises that target stubborn belly fat more effectively than crunches after ...

By 85, according to the Social Security Administration, it’s more like 10 percent. Death comes quickly.) Soon after the carry ...

By 85, according to the Social Security Administration, it’s more like 10 percent. Death comes quickly.) Soon after the carry-on incident, Scott saw an advert for an experimental gene therapy from a ...

Researchers report a python metabolite that suppresses appetite in mice, highlighting a potential alternative to current weight-loss drugs. The study, set against widespread use of GLP-1 drugs such as ...

People in their 50s often feel good about life, sometimes more settled and confident than before. At the same time, the body starts doing things no one really prepared you for.

Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related ...

Malnutrition among the older population is not a problem unique to Singapore. As people age, health problems and social ...

Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology company $19 million financings to advance lead clinical candidate PTC-2105 for sarcopenia and age-related ...

GLP-1 medications affect metabolism by altering how our brains balance fat burning and fat storage. They make it slightly ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Discover how functional medicine and gut health can extend your healthspan. Read the latest longevity science.

Pulmatrix may have been discarded by Cullgen, but the inhaled therapy biotech’s Nasdaq listing has caught the attention of ...